
What stands out here is that HCN will be raising gross proceeds from the offering of roughly $988 million from the face value of the sale, or about $1.1 billion if the overallotment option is exercised in full. The company’s market cap was $20.5 billion as of Thursday’s close. Another issue is that Health Care REIT’s dividend yield is now close to 5% again, since its shares have sold off.
Another boost here is that the share sale proceeds are going to the company. HCN said in the filing that it intends to use the capital raised to repay advances under its primary unsecured credit facility. It also plans to use the capital for general corporate purposes, which it specified as saying could be used to invest in health care and seniors housing properties.
Goldman Sachs, RBC Capital Markets, Bank of America Merrill Lynch, Citigroup, Deutsche Bank, J.P. Morgan and Morgan Stanley were all listed as the joint book-running managers for the secondary offering.
Health Care REIT shares were indicated down about 3% and trading around $64.40 in the premarket. Its 52-week trading range is $52.43 to $68.36, and the consensus price target is $66.04.
READ ALSO: 5 Top Hospital Stocks to Buy Getting a Boost From the Affordable Care Act